So Mao Dayong had to nod.
"I see. The ultimate goal is to successfully develop new drugs."
"President Mao, we can't rest on our laurels. Our contract manufacturing business is already on track. If we can successfully develop a generic version of Trasima based on the information provided by Nosocomial Pharmaceuticals, our generic drug business will also be on track. However, we can't rest on our laurels. We must possess our own core competitiveness."
Mao Dayong understood that in order to become a real pharmaceutical company, it must have the ability to develop new drugs.
Moreover, if the new drug is successfully developed, the profit will not be 10%, but 30% or even 50%.
"Bring me the information I got from North."
Park Jin Hyuk said to Kim Jun Woo.
Five minutes later, Jin Junyu came back with the information.
Park Jin Hyuk placed the information in front of Mao Dayong.
"North's new drug, Datongling, has been in production for three months. This is the projected sales and profit for this year."
Mao Dayong took a look at the information.
The scope of application of North's new drug is wider than that of previously marketed drugs, and it is also cheaper.
Park Jin Hyuk said:
"In just three months, North's new drug achieved sales of 300 billion won (approximately 1.6 billion RMB) and a net profit of 100 billion won (approximately 530 million RMB). This is just the sales in North America. Sales in Europe, which began last month, are not yet included. Sales in Asia will also begin soon. If that happens, sales this year are expected to reach 1 trillion won (approximately 5.3 billion RMB) and net profit over 200 billion won (approximately 1.1 billion RMB). I'm sure you won't be surprised by such performance."
Continue read on readnovelmtl.com
